IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
Table 3
Comorbidities involving organs of mucosal immunity in patients with isolated IgA anti-β2GPI titer versus controls.